The disposition of drugs may differ between pregnant and nonpregnant animal
s, necessitating a change in dosage. We hypothesized that volume of distrib
ution or clearance may be different for aminoglycoside antibiotics in pregn
ant mares vs. nonpregnant lactating mares. To examine this hypothesis, we a
dministered gentamicin sulfate to seven Thoroughbred and Quarterhorse mares
on two occasions, followed by plasma drug gentamicin assay and pharmacokin
etic analysis. The first dose was administered 1-4 weeks before parturition
(mean weight 578 kg) and the second dose was administered in the period 1-
4 weeks after parturition (mean weight 518 kg). The dose administered at ea
ch time was approximately 6.6 mg/kg, intravenously (i.v.). Plasma gentamici
n concentrations were determined using fluorescence polarization immunoassa
y and pharmacokinetic analysis was performed using a two-compartment open m
odel. The plasma concentration vs. time profiles and total area-under-the-c
urve were almost identical for mares at late gestation vs. early lactation.
Mean volume of distribution at steady-state was 0.15 (+/- 0.02) and 0.16 (
+/- 0.03) L/kg, systemic clearance was 1.06 (+/-0.17) and 1.11 (+/- 0.17) m
L/kg/min, and mean (harmonic) elimination half-life was 2.2 and 2.1 h, for
pregnant and nonpregnant mares, respectively We concluded that there were n
o differences in drug distribution and clearance between pregnant and nonpr
egnant lactating mares. Gentamicin was also assayed in plasma of newborn fo
als after an injection of 6.6 mg/kg to three of the mares within 60 min of
parturition. Gentamicin was undetectable in plasma samples from these foals
and, therefore, apparently does not cross the placenta of mares at term.